The incidence of idiopathic thrombocytopenic purpura among adults: A population-based study and literature review

European Journal of Haematology

Volumn 83, Issue 2, 2009, Pages 83-89

  Abrahamson, Page E ^a   Hall, Susan A ^b   Feudjo Tepie, Maurille ^a   Mitrani Gold, Fanny S ^a   Logie, John ^a  

^a GLAXOSMITHKLINE   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

Epidemiology; Idiopathic thrombocytopenic purpura; Incidence; Review

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CLINICAL PRACTICE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 67650708740     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01247.x     Document Type: Article

References (27)

1. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997 84 : 222 43.
2. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998 45 : 419 25.
3. Clayton D, Hills M. Statistical Models in Epidemiology New York : Oxford Science, p. 86, 1994.
4. Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database:a rebuttal. J Thromb Haemost 2008 6 : 711 2.
5. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR, On behalf of the Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003 122 : 966 74.
6. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006 4 : 2377 83.
7. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999 94 : 909 13.
8. Anonymous. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003 120 : 574 96.
9. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005 56 : 425 42.
10. Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol 2004 75 : 12 7.
11. George JN. Idiopathic thrombocytopenia purpura in adults: current issues for pathogenesis, diagnosis and management. Hematol J 2004 5 (Suppl. 3 S12 4.
12. Nightingale AL, Farmer RD, de Vries CS. Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006 15 : 656 61.
13. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991 302 : 766 8.
14. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992 1 : 347 9.
15. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H. Validity of the general practice research database. Pharmacotherapy 2003 23 : 686 9.
16. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996 88 : 3 40. (Pubitemid 26230668)
17. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002 346 : 995 1008.
18. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern 1997 126 : 307 14.
19. Bottiger LE, Westerholm B. Thrombocytopenia. I. Incidence and aetiology. Acta Med Scand 1972 191 : 535 40.
20. Jacobs P, Wood L. Emergency surgery and refractory immune thrombocytopenic pupura. A case report. S Afr Med J 1986 69 : 321 2.
21. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In : Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. Vol. 5, New York : McGraw-Hill, 1995 : 1315 55.
22. Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 1960 53 : 861 76.
23. Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007 14 : 515 9.
24. Segal JB, Moliterno AR. Platelet counts differ by sex, ethnicity, and age in the United States. Ann Epidemiol 2006 16 : 123 30.
25. Terrel DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood 2005 105 : 1368 9.
26. Landgren O, Gridley G, Fears TR, Caporaso N. Immune thrombocytopenic pupura does not exhibit a disparity in prevalence between African American and white veterans. Blood 2006 108 : 1111 2.
27. Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis. Pediatr Blood Cancer 2006 47 : 653 6.